Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,959 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity.
Yamada Y, Takashima H, Walmsley DL, Ushiyama F, Matsuda Y, Kanazawa H, Yamaguchi-Sasaki T, Tanaka-Yamamoto N, Yamagishi J, Kurimoto-Tsuruta R, Ogata Y, Ohtake N, Angove H, Baker L, Harris R, Macias A, Robertson A, Surgenor A, Watanabe H, Nakano K, Mima M, Iwamoto K, Okada A, Takata I, Hitaka K, Tanaka A, Fujita K, Sugiyama H, Hubbard RE. Yamada Y, et al. Among authors: okada a. J Med Chem. 2020 Dec 10;63(23):14805-14820. doi: 10.1021/acs.jmedchem.0c01215. Epub 2020 Nov 19. J Med Chem. 2020. PMID: 33210531
Discovery of a potent dual inhibitor of wild-type and mutant respiratory syncytial virus fusion proteins through the modulation of atropisomer interconversion properties.
Yamaguchi-Sasaki T, Kawaguchi T, Okada A, Tokura S, Tanaka-Yamamoto N, Takeuchi T, Ogata Y, Takahashi R, Kurimoto-Tsuruta R, Tamaoki T, Sugaya Y, Abe-Kumasaka T, Arikawa K, Yoshida I, Sugiyama H, Kanuma K, Yoshinaga M. Yamaguchi-Sasaki T, et al. Among authors: okada a. Bioorg Med Chem. 2020 Dec 15;28(24):115818. doi: 10.1016/j.bmc.2020.115818. Epub 2020 Oct 31. Bioorg Med Chem. 2020. PMID: 33190073
Discovery of 7-methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole (TASP0382088): a potent and selective transforming growth factor-β type I receptor inhibitor as a topical drug for alopecia.
Amada H, Asanuma H, Koami T, Okada A, Endo M, Ueda Y, Naruse T, Ikeda A. Amada H, et al. Among authors: okada a. Chem Pharm Bull (Tokyo). 2013;61(3):286-91. doi: 10.1248/cpb.c12-00856. Chem Pharm Bull (Tokyo). 2013. PMID: 23449197 Free article.
Influences of advanced age in rheumatoid arthritis: A multicentre ultrasonography cohort study.
Kawahara C, Fukui S, Michitsuji T, Nishino A, Endo Y, Shimizu T, Umeda M, Sumiyoshi R, Koga T, Iwamoto N, Origuchi T, Ueki Y, Eiraku N, Suzuki T, Okada A, Matsuoka N, Takaoka H, Hamada H, Tsuru T, Arinobu Y, Hidaka T, Fujikawa K, Yoshitama T, Tada Y, Ohtsubo H, Ishizaki J, Asano T, Kawakami A, Kawashiri SY. Kawahara C, et al. Among authors: okada a. Mod Rheumatol. 2024 May 3:roae035. doi: 10.1093/mr/roae035. Online ahead of print. Mod Rheumatol. 2024. PMID: 38756078
Successful treatment of systemic lupus erythematosus with residual disease activity by switching from belimumab to anifrolumab.
Umeda M, Kojima K, Michitsuji T, Tsuji Y, Shimizu T, Fukui S, Sumiyoshi R, Koga T, Kawashiri SY, Naoki I, Iagawa T, Tamai M, Origuchi T, Furuyama M, Tsuboi M, Matsuoka N, Okada A, Aramaki T, Kawakami A. Umeda M, et al. Among authors: okada a. Mod Rheumatol. 2024 May 4:roae038. doi: 10.1093/mr/roae038. Online ahead of print. Mod Rheumatol. 2024. PMID: 38756072 No abstract available.
Change in Body Mass Index and Cardiovascular Outcomes in Patients With Cancer.
Ueno K, Kaneko H, Suzuki Y, Okada A, Fujiu K, Jo T, Takeda N, Kamiya K, Ako J, Morita H, Node K, Yasunaga H, Komuro I. Ueno K, et al. Among authors: okada a. Mayo Clin Proc. 2024 May 4:S0025-6196(24)00087-9. doi: 10.1016/j.mayocp.2024.02.003. Online ahead of print. Mayo Clin Proc. 2024. PMID: 38703179
1,959 results